stage cancers remains a priority. However, the cellular mechanisms involved in the progression of preneoplastic events to gastric cancer remain unclear. This lack of a clear understanding of the neoplastic transition hampers efforts to discover better screening methods for populations at risk. Thus, a more extensive knowledge of the preneoplastic events could clearly reduce gastric cancer mortality. In the following discussion we will review emerging concepts on the origin of preneoplastic metaplasia and the factors that infl uence conversion of metaplasia towards neoplasia.
Introduction
Gastric adenocarcinoma is the second leading cause of cancer-related death worldwide [1] . Gastric resection remains the critical step in gastric cancer therapy. Accordingly, the early detection and resection of early-Oxyntic atrophy in the setting of infl ammation can progress to the development of metaplasia. In humans, two types of metaplasia can arise from the presence of oxyntic atrophy and infl ammation: intestinal metaplasia and spasmolytic polypeptide-expressing metaplasia (SPEM). Both intestinal metaplasia and SPEM have been associated with the progression to intestinal-type gastric cancer [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . Thus, a case can be made for oxyntic atrophy in association with prominent infl ammation laying the groundwork for altered gastric lineages that are involved in the development of gastric cancer. However, the factors mediating the progression from oxyntic atrophy to gastric cancer remain unclear.
Intestinal metaplasia is characterized by the presence of intestinal goblet cells in the stomach [19] . Because intestinal goblet cells are not normally present in the stomach, intestinal metaplasia was originally proposed as the preneoplastic metaplasia leading to intestinaltype cancer [9] . Goblet cells in intestinal metaplasia express appropriate intestinal markers, including Muc2 and Trefoil factor 3 (TFF3) [20] . However, recent investigations have identifi ed a second possible preneoplastic metaplasia, SPEM. The mucous metaplastic lineages in SPEM display morphological characteristics more typical of deep antral gland cells or Brunner's glands, with expression of Muc6 and Trefoil factor 2 (TFF2) [16] . Despite the similarity between SPEM and the deep antral glands, no gastrin cells are observed in these glands. Recent studies have suggested that both SPEM and intestinal metaplasia may be preneoplastic metaplasias. In three separate studies, SPEM was associated with 90% of resected gastric cancers [16, 18, 21] . The exact infl uences promoting the sequential progression from oxyntic atrophy to metaplasia to dysplasia, however, remain unknown.
Parietal cell loss leads to metaplasia
The unresolved questions about the origin of oxyntic atrophy and its progression to gastric cancer are diffi cult to examine in humans, but mouse models are more amenable to answering these questions. As mentioned above, the most common predisposing factor for gastric cancer in humans is chronic H. pylori infections, resulting in oxyntic atrophy and prominent infl ammation. The importance of both oxyntic atrophy and the infl ammatory response has been examined in mice. Chronic infection of mice with H. pylori or with a different, but related, subspecies of Helicobacter felis results in profound loss of parietal cells and infl ammation throughout the mucosa, similar to that seen in humans [22] [23] [24] . H. felis-infected C57BL/6 mice develop SPEM after 6 months of infection, demonstrating that oxyntic atrophy and infl ammation can also lead to SPEM in mice. After 12 months of infection, the mice progress to gastritis cystica profunda, a dysplastic process in the fundic mucosa [22] . Importantly, however, the infected mice never develop intestinal metaplasia, suggesting that SPEM is the preneoplastic metaplasia in mice. The direct origin of SPEM, however, is diffi cult to elucidate from this chronic model complicated by the presence of both of the major predisposing factors: oxyntic atrophy and prominent infl ammation.
To isolate the role of oxyntic atrophy from the role of infl ammation in the development of SPEM, administration of pharmaceutical designation (DMP)-777 has been utilized to examine the role of acute oxyntic atrophy. DMP-777 is a cell-permeant neutrophil elastase inhibitor that ablates parietal cells without inciting an infl ammatory response. Loss of parietal cells is due to the secondary activity of DMP-777 as a parietal cellspecifi c protonophore. After 3 days of DMP-777 administration, mice develop oxyntic atrophy. The oxyntic atrophy gives rise to SPEM after 10 to 14 days of DMP-777 administration in the absence of infl ammation [25] . Thus, SPEM develops as a direct result of the loss of parietal cells. However, DMP-777-induced SPEM never progresses to dysplasia even after a year of administration [26] . These fi ndings demonstrate the important role of infl ammation in the progression to gastric neoplasia. Immunodefi cient mice infected with H. felis do not develop oxyntic atrophy and thus do not develop SPEM or progress to dysplasia [27] . Therefore, in the case of pharmacological ablation of parietal cells, no infl ammation is needed for parietal cell loss. More importantly, the parietal cell loss is suffi cient for the development of SPEM.
Cellular origin of metaplasia
Although oxyntic atrophy leads to the emergence of SPEM, the cellular origin of SPEM has remained elusive. Normal gastric cell lineages such as the parietal cell and mucous neck cell are derived from progenitor cells located in the upper region of the gland [28] [29] [30] [31] [32] . As the post-mitotic mucous neck cells migrate towards the base of the gland, they alter their expression profi les as well as their morphology to redifferentiate into chief cells (Fig. 1) [30, 33] . Because both mucous neck cells and chief cells have conventionally been thought of as post-mitotic, previously we had suggested that SPEM cells arise from a cryptic progenitor cell located at the base of the gastric glands. However, recent studies have suggested that, in fact, the chief cells (or a subset of chief cells) may transdifferentiate into SPEM cells [25, 34, 35] . Indeed, the most reliable pattern for the emergence of SPEM following induced oxyntic atrophy has been the identifi cation of cells at the bases of fundic glands expressing both intrinsic factor (a mouse chief cell marker) and TFF2 in different granules within the same cells [25] . One recent study demonstrated that some SPEM cells express Mist1, a chief cell differentiation-specifi c marker [35] . Moreover, this same study showed that SPEM cells located towards the base of the gland have an increase in the expression of minichromosome maintenance (MCM)3, which is involved in the initiation of genome replication. Occasionally, MCM3-positive cells were also observed at the bases of normal gastric glands in cells that coexpressed intrinsic factor, a chief cell marker in mice, suggesting that a subset of chief cells may retain or possibly can reactivate the ability to replicate [35] . Future studies are needed to investigate further the possibility that SPEM arises from chief cells, and more specifi cally, from the MCM3-positive chief cells. Nevertheless, present information supports the origin of SPEM from cells distinct from the normal mucosal progenitor cells located in the gland neck.
The origin of intestinal metaplasia has been harder to elucidate because Helicobacter infection in mice does not result in intestinal metaplasia. However, H. pylori infection of other species, such as Mongolian gerbils, does induce intestinal metaplasia [36, 37] . Moreover, H. pylori infection-induced intestinal metaplasia evolves into gastric cancer in older Mongolian gerbils [38] [39] [40] . Detailed examination of the histological progression of oxyntic atrophy to gastric cancer in the Mongolian gerbil has shed some light into the origin of intestinal metaplasia and its association with SPEM [40] . After only 3 weeks of infection, the gerbils developed SPEM in the presence of oxyntic atrophy. The emergence of intestinal metaplasia followed later, at 24 and 39 weeks of infection. Importantly, the sites of intestinal metaplasia were surrounded by the preexisting SPEM. Moreover, single glands contained both intestinal metaplasia and SPEM [40] . Similar developmental patterns of intestinal metaplasia have also been observed in humans [41] . The fi ndings in these studies suggest that oxyntic atrophy results in the development of SPEM, which, in turn can then evolve into intestinal metaplasia (Fig. 2) . However, conclusive evidence of this progression has evaded researchers so far. Future studies in mouse models of SPEM and intestinal metaplasia are needed to trace this progression of metaplastic lineages. Until these studies are conducted, three hypotheses must be considered. First, each type of metaplasia (intestinal metaplasia or SPEM) may lead to a distinct type of cancer. For example, SPEM may progress to gastrictype cancers while intestinal metaplasia proceeds to intestinal-type cancers. Alternatively, one of the metaplasias could be the preneoplastic metaplasia, while the other is merely associated with cancer. The third hypothesis based on the Mongolian gerbil studies is that SPEM develops fi rst, progresses to intestinal metaplasia, and fi nally evolves into gastric cancer. More extensive studies comparing both the transcript and protein expression patterns of metaplastic lineages to the patterns of gastric adenocarcinomas may provide insights into the links between metaplastic lineages and cancer.
Another aspect of this progression that must be considered, though it is not frequently mentioned, is the geographical origin of these metaplastic lesions within the stomach. SPEM and the resulting intestinal metaplasia found in H. pylori-infected Mongolian gerbils initiated along the lesser curvature of the stomach and expanded towards the greater curvature during longer terms of infections [40] . This concentration of metaplastic lineages along the lesser curvature has also been documented in humans [41, 42] . Additionally, H. pylori preferentially colonizes the lesser curvature both in mouse models and in humans [43, 44] . This localization of metaplastic initiation in both rodents and humans may be the result of Helicobacter sp. colonization patterns. However, there may also be an underlying factor for this convergence on the lesser curvature that has yet to be discovered. For example, the cellular lineage composition of the lesser curvature may vary from that of the greater curvature to account for these differences in the location of metaplastic initiation. Interestingly, the human stomach has not yet been extensively mapped out. It will be interesting to know the full extent of the differences in lineage distributions between the two curvatures and how they correspond with H. pylori colonization and the origin of metaplasia.
It is also necessary to consider the other geographical axis when examining the origin of metaplasias. Unlike the possible lineage differences between the two curvatures, there are known differences in the cell lineages between the fundus and the antrum of the stomach. Although parietal cells play a crucial signaling role in the fundus, they are not found in the antrum. Chief cells are also not located in the antrum. Instead, antral glands have a TFF2-expressing lineage that populates the base of the glands. The antrum also contains other cell lineages not found in the fundus, such as gastrinexpressing G cells. Gastrin plays an important role in acid secretion as well as proliferation in the fundus [45, 46] . Knocking out gastrin creates a hypogastrinemic environment which results in a reduction in parietal cell mass in the fundus and chronic infl ammation in the antrum. This antral infl ammation leads to an increase in intestinal markers such as villin and mucin (MUC)2, although goblet cell morphology is not seen. Eventually, tumors develop in the antrum in 12-month-old gastrin-defi cient mice [47] . Interestingly, another mouse model, the TFF1 knockout mouse, also results in antral tumors, although more quickly. TFF1, unlike gastrin, is In the presence of chronic infl ammation from Helicobacter pylori infection, SPEM evolves into intestinal metaplasia and then progresses on to gastric cancer. Establishment of biomarkers of these metaplastic lineages is a priority. Recent studies in mice identifi ed HE4 as a SPEM biomarker. In humans, HE4 is not expressed in the cells of the normal fundus. However, HE4 is detected in both SPEM and intestinal metaplasia (IM), supporting the hypothesis of SPEM progression to intestinal metaplasia normally expressed in surface cells throughout the entire stomach. Mice lacking TFF1 expression develop antral tumors at 5 months of age [48] . Both mouse models suggest an important role for gastrin and TFF1 in maintaining normal differentiation of the antrum. A third mouse model combines the effect of gastrin and TFF1 loss. The gp130 mouse contains a mutation that inhibits SHP2 binding to the interleukin (IL)-6 family coreceptor gp130. This binding inhibition results in decreases in gastrin and TFF1 expression, as well as an increase in signal transducer and activator of transcription (STAT)3 expression. These aberrant expression patterns result in antral tumors at 6 weeks of age, which quickly extend into the fundus by around 17 weeks of age. Additionally, these tumors are accompanied by SPEM [49] . Thus, the combined effect of gastrin loss with TFF1 loss accelerates the development of antral tumors in mice. Moreover, this model resembles antral tumor development in humans. Together, gastric tumor models, in mice and Mongolian gerbils, demonstrate how metaplasias of the stomach and gastric cancer may originate and progress differently depending on the geographical location and possibly local regulatory signals.
Regulation of metaplasia
While oxyntic atrophy is directly responsible for the development of SPEM, the emergence of SPEM can be altered by endocrine or paracrine regulation. As stated above, parietal cells produce instructive signaling for the growth and differentiation of the other gastric lineages. However, parietal cells also receive signals from other cell types in the gastric mucosa, such as the previously mentioned gastrin-secreting G cells and histamine-secreting enterochromaffi n-like (ECL) cells [50] [51] [52] [53] [54] [55] [56] . Gastrin stimulates ECL cell release of histamine, the primary stimulator of acid secretion from parietal cells [51] . Histamine secreted by the ECL cells also plays an important role in the differentiation of the gastric lineages [57] . At the same time, somatostatin cells coordinate inhibitory infl uences both on acid secretion and hormonal secretion [58] . Thus, parietal cells, G cells, somatostatin cells, and ECL cells coordinate with each other to regulate the gastric mucosal milieu. Understandably then, the disruption of this balance of intramucosal factors affects the maturation of normal gastric lineages as well as the development of SPEM. For example, gastrin-defi cient mice develop SPEM after only 1 day of DMP-777 administration, while it takes 10 days of DMP777 administration for the development of SPEM in wild-type mice [25] . Similarly, histidine-decarboxylase (HDC)-defi cient mice (which lack histamine) also have an accelerated development of SPEM upon administration of DMP-777 [57] . These studies highlight the complex coordination that occurs between the different cell lineages of the stomach.
Additionally, other intramucosal paracrine factors such as growth factors are important in the regulation of metaplasia. To examine the role of the EGF signaling pathway in the development of SPEM, the waved-2 mouse was utilized, because it has a reduction in the EGF receptor tyrosine kinase activity. Upon administration of DMP-777, accelerated development of SPEM was observed in the waved-2 mice [59] . Further investigations into this signaling pathway demonstrated that different EGF receptor ligands affected the mucosal lineages differently. DMP-777-induced SPEM in TGFα-defi cient mice developed similarly to that seen in wild-type mice. In contrast, loss of amphiregulin led to accelerated SPEM development [60] . Taken together, these fi ndings demonstrate that the emergence of SPEM is regulated by a complex coordination of both endocrine and paracrine factors. While loss of a single factor may alter SPEM development, no factor has been found to be solely responsible for the emergence of SPEM.
Metaplastic progression to gastric cancer
Infl ammation plays an important role in the development and progression of SPEM. As stated before, while SPEM can develop in the absence of infl ammation, it does not progress to dysplasia without infl ammation. Helicobacter infections in mice progress to dysplasia when prominent infl ammation is present [61] . The infl ammatory response observed in these mice is composed mostly of a T-helper (Th)1 response [62] . Interestingly, further investigation into the components of infl ammation has led to the discovery that the type of infl ammatory response is important in the progression to gastric cancer. In mice with a Th2-dominant infl ammatory response to H. felis infection, the SPEM did not progress to dysplasia [63] . Thus, a Th1-dominant infl ammatory response is needed for the progression of SPEM to dysplasia in mice. Other factors involved in the progression to neoplasia have been diffi cult to elucidate, possibly because of gaps in our knowledge of the progression from metaplasia to dysplasia.
One recent study suggested a role for bone marrowderived cells (BMDCs) within this progression [64] . This study found that BMDCs were recruited to the stomach during chronic H. felis infection. These recruited BMDCs appeared to engraft into the SPEM glands and progress to gastritis cystica profunda [64] . No engraftment was observed in models of SPEM without infl ammation, such as DMP-777 treatment. It also remains unclear whether BMDCs adopt the SPEM phenotype or actually fuse with SPEM cells during engraftment. At this time it remains uncertain whether this engraftment of SPEM by BMDCs is specifi c to infection with the H. felis strain, and there remains no strong evidence to support a role for BMDCs in the evolution of metaplasia or cancer in humans.
Another issue to consider is the concept of fi eld cancerization and expansion of mutated clones. Field cancerization suggests that multiple stem cells form independent epithelial tumors [65] . Application of this concept to SPEM and intestinal metaplasia proposes that one of the stem cells in the gastric gland acquires a mutation. This mutated stem cell would then expand its mutated progeny until it eventually took over the gland and all the cell lineages present would have the mutation. The unit would then spread by gland fi ssion creating a fi eld of mutated gastric glands. A recent study applying this concept to intestinal metaplasia proposed that a gastric stem cell commits to the intestinal phenotype [66] . The progeny of the mutated stem cell would be seen mixed with normal gastric lineages as the stem cell proceeded to take over the gland. This could be one explanation for the mixed glands observed in the H. pylori-infected Mongolian gerbils [40] . It is possible that SPEM arises from transdifferentiation of the chief cells, while intestinal metaplasia is derived from a mutated stem cell born in the context of SPEM. Alternatively, intestinal metaplasia may represent a further mucous cell metaplastic differentiation that predisposes to the adoption and propagation of lineages with genetic mutations. If these concepts are correct, then SPEM and intestinal metaplasia may represent sequential steps in the progression to gastric cancer.
Future studies may result in biomarker discovery
Given the clear association of metaplasias in the stomach with increased risk for gastric cancer, the identifi cation of markers of metaplasia and metaplastic progression to dysplasia is a clear priority for the development of effective screening methods that could identify preneoplasia. The discovery of preneoplastic biomarkers would be of great value for earlier detection and treatment of preneoplastic lesions. Recent studies have begun to identify a number of biomarkers that have implications for cancer outcome. For example, a recent study identifi ed the secreted whey acidic protein (WAP) domain protein, HE4 (WFDC2) as a putative biomarker [35] . While there was no HE4 expression in normal gastric lineages, there was a prominent increase in expression in SPEM lineages from both DMP-777-treated and H. felis-infected mice (Fig. 1) . Similarly, HE4 was expressed in metaplastic lineages in humans (Fig. 2) . Through examination of human tissue arrays, HE4 was found to have strong expression in 100% of both SPEM and intestinal metaplasias. Additionally, strong HE4 expression is maintained in a number of intestinal-type gastric cancers, making it a promising biomarker candidate. However, a more expansive array of biomarkers is still needed to increase the diagnostic specifi city of metaplasias and preneoplastic events. As more biomarkers are established, diagnosis and treatments may be increasingly specialized based on the individual patient's biomarker expression patterns. Additionally, the discovery of new biomarkers will lead to a greater understanding of the molecular progression of normal gastric lineages to metaplasia (SPEM and intestinal metaplasia) and to cancer.
